This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Stay current on changes and developments in corporate law with a wide variety of resources and tools.
By Jacob Rund
Chinese acquisitions of U.S. companies dropped 56 percent in volume to $44.5 billion, dragged down by concerns about U.S. national-security deal reviews and shifts in China’s foreign investment policies.
The drop in Chinese-U.S. deal value to its lowest level since 2013 comes as overall cross-border acquisitions surged to $2.17 trillion, the highest total in nine years, Bloomberg Law data shows.
Deal lawyers attribute much of the slowdown to China’s tightened control on money leaving the country, but say U.S. scrutiny of China-based acquisitions has given some companies cause for hesitation.
“It does create caution in many people’s minds when Chinese buyers are involved,” Linda Ji, a partner in the Boston office of McDermott Will & Emery, told Bloomberg Law.
And while deal attorneys are optimistic that Chinese outbound investment will increase this year, there’s no consensus about how that will impact deals involving U.S. targets.
China has taken several steps since 2016 to curb the flow of investments in companies abroad, effectively slowing the pace of foreign acquisitions by its domestic companies.
China “was very much afraid of [a ton of] capital leaving the country,” said Liang Xu, a Beijing-based partner at Hogan Lovells who advises clients on cross-border deals.
At that time, cross-border deals were taking a toll on China’s foreign reserve, prompting it to reconsider its investment policies.
“They were concerned that an increase in transactions provided a legal channel for money to leave the country in the form of doing deals in the United States” and other nations, Xu said.
Among other steps, China restricted domestic companies from buying foreign firms with a higher valuation than their own.
The country last year also implemented a three-tiered system to control outbound foreign acquisitions. It restricted investments in industries including real estate and entertainment, and encouraged acquisitions related to infrastructure or advanced manufacturing. A third category prohibited investments in casinos and other gambling-related businesses.
The collective body of new foreign investment policies has “severely impacted the amount of transactions that Chinese buyers would be able to close,” Xu said.
President Donald Trump’s decision in September to block a Chinese-backed investor from buying U.S.-based Lattice Semiconductor Corp. added another layer of uncertainty.
Trump relied on a recommendation from the Committee on Foreign Investment in the United States, or CFIUS, which evaluates deals that may have national security concerns. The panel is chaired by the Treasury Secretary and has voting members from several government agencies, including the Defense and Justice Departments.
Concerns about the potential to clear CFIUS review recently derailed the sale of Moneygram International Inc. to Ant Financial—a Chinese company owned by Chinese billionaire Jack Ma.
CFIUS can take steps to unwind deals when the companies involved don’t submit the transactions for review, which attorneys interviewed by Bloomberg Law say has caused more companies to proactively file with the panel.
Only four CFIUS-reviewed deals have ever been blocked by U.S. presidents, all of which involved a Chinese company or investor.
“Buyers have become more cautious,” McDermott Will & Emery’s Ji told Bloomberg Law.
“Even in cases where parties don’t think the deal has any impact on U.S. national security, but the deal size is relatively large,” potential buyers have been more cautious, she said.
According to Ji, the work of cross-border deal attorneys has mostly stayed the same in the current climate. The most notable change during the past few years, she says, is simply CFIUS’ elevated profile.
Congress currently is debating two bills (H.R. 4311 and S. 2098) that would expand the scope of CFIUS’ review process to include more deals.
CFIUS is not, in most cases, an “absolute deterrent” for Chinese companies, although a lengthy review does add to the cost of a deal, Ji said.
Xu said Chinese buyers are aware they are the top target for CFIUS review and often appear more hesitant to consider a U.S. deal. Some companies are “turning away from the U.S. and taking a closer look in countries like the United Kingdom or Germany.”
“I think CFIUS has always been a wild card,” said George Georgiev, a business law professor at Emory University and a former corporate attorney with Sullivan & Cromwell LLP. “When you don’t have regulatory certainty, it creates problems.”
Both Ji and Xu say more clarity surrounding the Chinese currency transfer restrictions will spur an uptick in outbound acquisitions coming from China this year.
“There are signs that signal the Chinese regulatory regime is stabilizing,” Xu said, which “would make it easier for money to leave China.”
However, large transactions between Chinese acquirers and U.S. targets are “probably going to slow down in 2018,” he said. “Because of CFIUS and other conservative positions of the Trump administration, I think that Chinese deals in the U.S. will still be tough this year.”
Ji, holding a more optimistic view, said a potential increase in outbound Chinese investment means more deals could head to the U.S. These transactions, though, will still need to fit the criteria imposed by the Chinese government, she said.
“It’s difficult to read the tea leaves,” Georgiev said. “In terms of the regulatory landscape, I don’t see any reason to expect a reversal of the [downward] trend that started last year.”
To contact the reporter on this story: Jacob Rund at jrund@bloomberglaw.com
To contact the editor responsible for this story: Yin Wilczek at ywilczek@bloomberglaw.com
Copyright © 2018 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to books@bna.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to research@bna.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)